SequelSEC

Alpha Cognition Inc. ACOG

Biological Products, (No Diagnostic Substances) · CIK 0001655923 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$6.09M
Fiscal year ended 2026-06-30
Operating income
-$7.76M
Fiscal year ended 2026-06-30
Free cash flow
-$6.96M
Fiscal year ended 2026-06-30

Alpha Cognition Inc. (ACOG) reported revenue of $6.09M and net income of -$8.79M for the fiscal year ended 2026-06-30. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Alpha Cognition Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

Alpha Cognition Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Revenue$6.09M$3.53M$2.79M$2.84M$1.66M$2.93M
Cost of revenue$391.06KUnavailableUnavailableUnavailable$203.86K$12.69K
Gross profit$5.70MUnavailableUnavailableUnavailable$1.45MUnavailable
Operating income-$7.76M-$8.10M-$7.93M-$5.31M-$8.45M-$3.40M
Net income-$8.79M-$6.48M-$6.86M-$1.32M-$13.20M-$1.73M
Research & development$2.01M$1.10M$569.75K$573.59K$406.14K$400.42K
Weighted-average diluted sharesshares 21.77Mshares 21.93MUnavailableshares 16.14Mshares 16.02Mshares 16.02M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.40$-0.32Unavailable$-0.30$-0.82$-0.11
Selling, general & administrative$11.45M$10.26M$9.89M$6.95M$9.49M$5.09M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Alpha Cognition Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Cash & equivalents$41.38M$54.25M$66.05M$35.40M$39.41M$45.53M
Total assets$64.52M$69.25M$79.73M$46.30M$45.12M$48.61M
Current assets$57.93M$68.56M$79.01M$45.70M$44.65M$48.12M
Total liabilities$11.56M$11.79M$17.20M$12.39M$13.23M$7.80M
Current liabilities$6.41M$5.43M$9.13M$6.83M$3.04M$2.81M
Total equity incl. NCI$52.96M$57.46M$62.53M$33.91M$26.72M$38.50M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$6.39M$6.04M$5.12M$4.50M$875.85K$883.38K
Accounts receivable$5.47M$3.58M$4.24M$2.85M$1.81M$422.80K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$1.19M$1.43M$3.07M$838.01K$752.33K$821.87K

Cash flow

Alpha Cognition Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Operating cash flow-$6.86M-$11.80M-$6.91M-$5.29M-$6.14M-$2.04M
Capital expenditures$98.57K$1.32K$147.52K$74.38K$8.32K$63.27K
Investing cash flow-$6.01M-$1.32K-$147.52K-$74.38K-$8.32K-$63.27K
Financing cash flow$0$800$37.70M$1.36M-$10.81K-$834.30K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$1.45M$1.40M$945.50K$1.46M$1.39M$1.13M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$103.59K$29.77K$27.12K$12.55K$11.61K$7.28K

Derived

Alpha Cognition Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Free cash flow-$6.96M-$11.80M-$7.05M-$5.36M-$6.15M-$2.11M
Gross margin93.6%UnavailableUnavailableUnavailable87.7%Unavailable
Operating margin-127.3%-229.1%-283.7%-187.0%-509.6%-116.3%
FCF margin-114.2%-333.9%-252.6%-188.8%-370.9%-72.0%
SBC / revenue23.8%39.7%33.9%51.3%83.8%38.6%
Current ratio9.03x12.64x8.65x6.69x14.69x17.14x
Revenue YoY growth267.6%20.7%UnavailableUnavailableUnavailableUnavailable
Net margin-144.3%-183.3%-245.5%-46.4%-796.2%-58.9%
R&D / revenue33.0%31.0%20.4%20.2%24.5%13.7%
CapEx / revenue1.6%0.0%5.3%2.6%0.5%2.2%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACOG in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

ABOS ABPO ADAPY ADMA ADPT AGEN AGTX AIM ALEC ALGS ALLO AMGN

Reconciliation checks needing review

3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2025-03-31

Withheld: gross profit could not be reconciled with the rest of this filer’s statement.

balance equationreview2025-06-30

Difference 5180508 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2025-03-31

Difference 2311046 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.